Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

N-acetyl-DL-leucine, neuroprotective and retinoprotective medicament

A leucine, protective technology for the production of neuroprotective and retinal protective drugs (or pharmaceuticals) that addresses issues such as the unknown potential for ophthalmic applications

Inactive Publication Date: 2013-05-01
拉乌夫·雷基克
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] Despite the beneficial effects of N-acetyl-DL-leucine on vertigo, its potential for ophthalmic applications was not known prior to this invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N-acetyl-DL-leucine, neuroprotective and retinoprotective medicament
  • N-acetyl-DL-leucine, neuroprotective and retinoprotective medicament
  • N-acetyl-DL-leucine, neuroprotective and retinoprotective medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0162] The numerical indications given below should not be considered as limiting the invention per se, as they can be determined by the physician and his or her patient, the following daily doses of the active ingredient (e.g., N-acetyl-DL-leucine) It is effective when administered orally at a dose of 2 grams per day; or at a concentration of 2% when administered in the form of eye drops. It is clear that the dose may vary from patient to patient and that is ultimately a matter for the clinician.

[0163] Topical administration forms, especially eye drops, are clearly preferred here. They have proven to be particularly effective.

[0164] In other words, the active ingredient (for example, N-acetyl-DL-leucine) is combined with one or several pharmaceutical carriers enabling clinical use in the form of eye drops.

[0165] The invention can be further illustrated by the following description of clinical examples, which of course do not limit the invention per se. In these ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament, the active principle of which is a leucine and, for example, a N-ACETYL-DL-LEUCINE. It can be applied to the prevention and / or treatment of eye diseases or disorders and especially of hereditary dystrophies of the retina, glaucomatous neuropathy, glaucoma, macular degeneration, myopia, presbyopia, hypermetropia, astigmatism, all the ophtalmologic diseases or disorders inducing a decrease of visual function and / or age-related physiological vision decline.

Description

technical field [0001] The present invention relates to the production of medicaments, in particular neuroprotective and retinal protective medicaments (or medicaments) for the prevention and / or treatment of ocular diseases resulting in damage to the retina and optic nerve which can lead to vision (especially loss of near and far visual acuity, contrast vision, color vision and / or visual field). These drugs contain at least one active ingredient that is leucine, eg, N-acetyl-DL-leucine. This leucine can be combined with other active ingredients, especially Ramipril or Ramiprilate. Background technique [0002] The present invention aims to provide medicines for preventing and / or treating eye diseases or disorders, which can improve vision function, especially distance vision acuity and / or near vision acuity, contrast vision, Color vision and / or visual field. Examples of such diseases or disorders that may be mentioned are: [0003] - Inherited retinal dystrophies such as...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/00A61K31/198A61P27/02
CPCA61K31/198A61K45/06A61P3/06A61P9/10A61P9/12A61P19/02A61P21/02A61P21/06A61P25/00A61P25/16A61P27/00A61P27/02A61P27/06A61P27/10A61P29/00A61P31/00A61P35/00A61P37/00A61P43/00
Inventor 拉乌夫·雷基克
Owner 拉乌夫·雷基克
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com